<DOC>
	<DOCNO>NCT00139750</DOCNO>
	<brief_summary>The purpose study examine safety efficacy dose-response relationship three dose CP-526,555 12 week compare placebo smoke cessation ; include post-treatment follow-up smoking status one year randomization . A small satellite protocol ( A3051048 ) investigate safety second course therapy subject quit .</brief_summary>
	<brief_title>12 Week Evaluation Safety Efficacy 3 Doses CP-526,555 Placebo Smoking Cessation</brief_title>
	<detailed_description />
	<mesh_term>Varenicline</mesh_term>
	<criteria>Cigarette smoker motivate stop smoking smoked average least 10 cigarette per day Subjects use nicotine replacement product within 30 day study screen visit intend use study .</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>June 2007</verification_date>
</DOC>